Radiopharm Theranostics Limited (AU:RAD) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Radiopharm Theranostics Limited has confirmed that it marked a recent announcement as price sensitive, highlighting its potential impact on the company’s stock value. The company became aware of the information on December 5th and promptly prepared to release it, ensuring compliance with ASX listing rules. This proactive approach aims to maintain transparency and investor confidence amidst notable trading activity.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.